We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+7.53%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$162M
Cap. Flow
+$141M
Cap. Flow %
13.21%
Top 10 Hldgs %
37.33%
Holding
532
New
105
Increased
323
Reduced
47
Closed
36

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$9.31M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.32M
3
NVDA icon
NVIDIA
NVDA
+$6.63M
4
MSFT icon
Microsoft
MSFT
+$6.29M
5
UGL icon
ProShares Ultra Gold
UGL
+$5.95M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$5.72M
2
PDD icon
Pinduoduo
PDD
+$4.15M
3
PG icon
Procter & Gamble
PG
+$2.96M
4
SNPS icon
Synopsys
SNPS
+$2.64M
5
AMAT icon
Applied Materials
AMAT
+$2.41M

Sector Composition

Rank Sector Weight
1 Technology 38.03%
2 Healthcare 25.43%
3 Consumer Discretionary 12.38%
4 Communication Services 10.24%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCHP icon
251
Microchip Technology
MCHP
$43.1B
$501K 0.05%
8,739
+1,934
+28% +$133K
ARWR icon
252
Arrowhead Research
ARWR
$12.3B
$496K 0.05%
26,385
+2,475
+10% +$51K
PTGX icon
253
Protagonist Therapeutics
PTGX
$9.84B
$488K 0.05%
12,637
+1,308
+12% +$57K
ANSS
254
DELISTED
Ansys
ANSS
$480K 0.04%
1,423
+315
+28% +$106K
IOVA icon
255
Iovance Biotherapeutics
IOVA
$3.05B
$478K 0.04%
64,625
+6,249
+11% +$57.9K
CSGP icon
256
CoStar Group
CSGP
$12.4B
$478K 0.04%
6,672
+1,474
+28% +$111K
IDYA icon
257
IDEAYA Biosciences
IDYA
$3.56B
$471K 0.04%
18,327
+2,078
+13% +$58.8K
GERN icon
258
Geron
GERN
$1.01B
$454K 0.04%
128,176
+12,239
+11% +$48.9K
ZS icon
259
Zscaler
ZS
$28.7B
$450K 0.04%
2,497
+580
+30% +$112K
TARS icon
260
Tarsus Pharmaceuticals
TARS
$3.07B
$449K 0.04%
8,106
+789
+11% +$35.8K
BEAM icon
261
Beam Therapeutics
BEAM
$2.76B
$441K 0.04%
17,794
+1,707
+11% +$43.6K
ON icon
262
ON Semiconductor
ON
$32.4B
$437K 0.04%
6,929
+1,496
+28% +$103K
APGE icon
263
Apogee Therapeutics
APGE
$10.2B
$432K 0.04%
9,547
+892
+10% +$45.5K
LGND icon
264
Ligand Pharmaceuticals
LGND
$5.85B
$429K 0.04%
4,007
+493
+14% +$55.7K
WBD icon
265
Warner Bros
WBD
$69.3B
$422K 0.04%
39,923
+8,823
+28% +$82K
MIRM icon
266
Mirum Pharmaceuticals
MIRM
$6.04B
$421K 0.04%
10,179
+1,003
+11% +$41.8K
HRMY icon
267
Harmony Biosciences
HRMY
$2.32B
$416K 0.04%
12,093
+1,162
+11% +$39.9K
AKRO
268
DELISTED
Akero Therapeutics
AKRO
$412K 0.04%
14,800
+1,446
+11% +$43.8K
CGON icon
269
CG Oncology
CGON
$6.82B
$411K 0.04%
+14,340
New +$491K
THC icon
270
Tenet Healthcare
THC
$21.5B
$410K 0.04%
+3,250
New +$483K
CCL icon
271
Carnival Corporation Ltd
CCL
$37.9B
$405K 0.04%
16,248
+7,631
+89% +$179K
IRON icon
272
Disc Medicine
IRON
$3.09B
$400K 0.04%
6,310
+593
+10% +$34.3K
AGIO icon
273
Agios Pharmaceuticals
AGIO
$2.04B
$397K 0.04%
12,092
+1,150
+11% +$54K
GFS icon
274
GlobalFoundries
GFS
$29.2B
$386K 0.04%
8,994
+1,998
+29% +$83.7K
AMPH icon
275
Amphastar Pharmaceuticals
AMPH
$850M
$379K 0.04%
10,195
+833
+9% +$38.1K
9 10
11
12 13

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q4 2024 Portfolio in Review

As of Q4 2024, China Universal Asset Management Company held 532 positions worth $1.07B, up 18% from $907M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

China Universal Asset Management Company deployed $141M of net new capital in Q4 2024, opening 105 new positions and adding to 323 existing holdings. Its largest new stake was Astera Labs: 26,000 shares worth $3.44M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Pinduoduo, an estimated $4.15M trimmed.

  • China Universal Asset Management Company's largest Q4 2024 buy was Astera Labs: 26,000 shares worth $3.44M.
  • China Universal Asset Management Company added most to Apple in Q4 2024, an estimated $9.31M increase.
  • China Universal Asset Management Company's biggest Q4 2024 reduction was Pinduoduo, cutting an estimated $4.15M.
  • China Universal Asset Management Company fully exited Alibaba in Q4 2024, selling an estimated $5.72M.
  • China Universal Asset Management Company's ten largest holdings make up 37% of its $1.07B portfolio in Q4 2024.
  • China Universal Asset Management Company opened 105 new positions and closed 36 in Q4 2024.
  • China Universal Asset Management Company's portfolio value rose 18% quarter-over-quarter to $1.07B.

Based on China Universal Asset Management Company's 13F filing for Q4 2024, filed 24 Jan 2025.